Adolescent Chlamydia Screening in Pediatric Primary Care: A Quality Improvement Project.

The implementation period was short, and screening rates decreased after the active project. The project was done at three sites in one pediatric network, and the text did not state the number of adolescents analysed. The intervention was a bundle, so the effect of any single component cannot be separated. Urine testing was used, although vaginal sampling is preferred for chlamydia screening, because vaginal swabs were not routine. Confidentiality risks remained because of electronic health record documentation, insurance billing, and outside laboratories. Handout distribution was not monitored, so a planned feasibility measure was missing. The original baseline aim used only assigned female sex at birth, while the project later included all adolescents. The main outcome was screening rate and case detection, not long-term health outcomes.

The authors reported no competing interests or financial disclosures. A physician-based financial incentive for STI screening of sexually active females was already in place, and providers could receive American Board of Pediatrics MOC credit.

Do not conclude that universal opt-out screening prevents chlamydia complications or will sustain itself. The project measured screening rates and case detection, not long-term health outcomes, and screening rates decreased after implementation. The workflow also included handouts, education, urine collection changes, consent steps, and provider incentives, so no single element can be credited.